More articles from Review

  • Radiologic imaging in rhinosinusitis
    Pete S. Batra, MD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 886-888;

    Imaging may be necessary for rhinosinusitis that is refractory, chronic, recurrent, or complicated.

  • A guide to informed consent for clinician-investigators
    Katrina A. Bramstedt, PhD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 907-910;

    Informed consent is a process, not a form. It is a legal and ethical safeguard to ensure that subjects enter studies voluntarily and fully informed.

  • Dementia with Lewy bodies: Diagnosis and clinical approach
    David S. Geldmacher, MD
    Cleveland Clinic Journal of Medicine October 2004, 71 (10) 789-800;

    Not all dementia is Alzheimer disease: dementia with Lewy bodies is the second most common cause, and the distinction may matter.

  • Treating osteoporosis in postmenopausal women: A case approach
    Michael I. Keller, MD
    Cleveland Clinic Journal of Medicine October 2004, 71 (10) 829-837;

    We now have several agents of different classes for treating postmenopausal osteoporosis. In this paper, a case report serves as the focus for a discussion of the risk factors for postmenopausal osteoporosis and of the available therapies.

  • Hospital management of diabetes: Beyond the sliding scale
    Etie Moghissi, MD
    Cleveland Clinic Journal of Medicine October 2004, 71 (10) 801-808;

    Tight glucose control has been shown to improve clinical outcomes in hospitalized patients. The challenge now is implementation.

  • Drug-eluting stents: The beginning of the end of restenosis?
    Drug-eluting stents: The beginning of the end of restenosis?
    Cameron Haery, MD, Ravish Sachar, MD and Stephen G. Ellis, MD
    Cleveland Clinic Journal of Medicine October 2004, 71 (10) 815-824;

    Drug-eluting stents are here, and they are better than ordinary stents. But how much better?

  • Homocysteine: Is it a clinically important cardiovascular risk factor?
    Steven R. Lentz, MD, PhD and William G. Haynes, MD
    Cleveland Clinic Journal of Medicine September 2004, 71 (9) 729-734;

    The jury is still out as to whether homocysteine is a cause, consequence, or marker of cardiovascular disease. B vitamins lower homocysteine levels; whether they reduce risk is also unknown, but they are cheap and safe.

  • Hypertension treatment in African Americans: Physiology is less important than sociology
    David Martins, MD and Keith Norris, MD
    Cleveland Clinic Journal of Medicine September 2004, 71 (9) 735-743;

    Social, cultural, and economic barriers to care are probably more important than any true physiologic differences between races.

  • Evaluation of hyponatremia: A little physiology goes a long way
    Benjamin J. Freda, DO, Michael B. Davidson, DO and Phillip M. Hall, MD
    Cleveland Clinic Journal of Medicine August 2004, 71 (8) 639-650;

    A careful and logical approach can promptly reveal the causative factor or factors in nearly all cases.

  • Nonalcoholic fatty liver disease and the epidemic of obesity
    Rochelle Collantes, MD, MPH, Janus P. Ong, MD and Zobair M. Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine August 2004, 71 (8) 657-664;

    Nonalcoholic fatty liver disease, unknown only 2 decades ago, is now ubiquitous, especially among the obese.

Pages